Blog icon

Our COVID-19 vaccine research

We are working on the testing and manufacture of a vaccine for the novel coronavirus responsible for causing COVID-19.

COVID-19 vaccine testing

Our preclinical trials of leading vaccine candidates supported the global race against the pandemic to help find a safe and effective COVID-19 vaccine.

COVID-19 vaccine manufacture

We worked with vaccine developers to produce small volumes of candidate vaccines to the highest quality standards, for use in trials. If successful, our manufacturing process can be scaled with an industry partner.

COVID-19 research

Read more about our work to protect Australians from COVID-19.

COVID-19 Antiviral research

Antiviral drugs for COVID-19

We are working with the research sector and industry on the preclinical evaluation of potential antiviral drugs, to see if they are effective against COVID-19.

Other vaccine and drug research

Rotavirus vaccine

We are supporting not-for-profit global health organisation PATH in their rotavirus vaccine development project, benefiting communities globally.

Hendra vaccine

Equivac® HeV–the first vaccine to protect Australian horse owners and the equine industry against the deadly Hendra virus.

Relenza flu drug

Our expertise in determining protein structure and therapeutic design led to the development of Relenza, the first drug successful in treating the flu.

A future where antibiotics still save lives

Minimising Antimicrobial Resistance

We will work to halt the rising death rate and economic burden of antimicrobial resistance (AMR) in Australia by 2030.

Vaccine research blogs

Visit our CSIROscope blog for features and articles about our vaccine research.

All our vaccine and antiviral research